FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079301085> ?p ?o ?g. }

• W2079301085 endingPage "1025" @default.
• W2079301085 startingPage "1023" @default.
• W2079301085 abstract "To the Editor: Certain arthropod-borne epornitic flaviviruses, namely, West Nile virus (WNV) and Usutu virus (USUV), have spread recently in parts of Europe (1,2). In southern Spain, the emergence of a third virus of this type, known as Bagaza virus (BAGV), is of concern (3). Because of the outbreaks in 2010 in Cadiz (southern Spain) of WNV infection, which affected birds, horses, and humans, and of BAGV infection, which affected game birds (partridges and pheasants), and the reported presence of USUV in mosquitoes in this area (4), a surveillance program was implemented in partridges and pheasants during the next hunting season (October 2011–February 2012) to assess the possible circulation of these 3 flaviviruses in the area.Serum samples and brain tissue from 159 hunted-harvested wild red-legged partridges (Alectoris rufa) and 13 common pheasants (Phasianus colchicus) were collected on 12 hunting properties from Cadiz (Technical Appendix Figure). All sampled birds were reared and shot in the wild. The age of the partridges was determined according to plumage characteristics.Presence of antibodies against WNV was tested with a commercial epitope-blocking ELISA (Ingezym West Nile Compac, INGENASA, Madrid, Spain) (5). Virus-neutralization titers against WNV (strain Eg-101), BAGV (strain Spain/2010), and USUV (strain SAAR1776) were determined by micro virus neutralization test (VNT) as described (6).Viral genome in brain tissue samples was examined by heminested pan-flaviviral reverse transcription PCR (7). All 172 tissue homogenates examined were negative by this test.Overall seroprevalence for WNV by epitope-blocking ELISA was 29%. Prevalence of neutralizing antibodies measured by VNT was 23% for WNV, 15% for BAGV, and 10% for USUV. Seroprevalence rates were higher for pheasants than for partridges for WNV (Fisher exact test, p = 0.0003), BAGV (p<0.0001), and USUV (p<0.0001) (Table). The significance of this result is uncertain, given that just 2 hunting areas were sampled for pheasants.TableResults of serologic studies in red-legged partridges and common pheasants, southern Spain, 2011–2012*Neutralizing antibodies to >1 flavivirus were detected in 15 of the 45 VNT-positive partridges and in 6 of the 12 VNT-positive pheasants (Table). Specificity, as determined by neutralizing antibodies titer comparisons (8), showed virus-specific neutralizing antibodies to WNV, BAGV, and USUV in 19 partridges, 9 partridges, and 1 partridge, respectively, in 3 pheasants to WNV and in another 3 pheasants to BAGV (0 to USUV). Serum from 9 partridges and 6 pheasants remained inconclusive (neutralizing antibodies titer differences <4-fold [8]). WNV-reacting antibodies by ELISA were shown in 11 of 12 hunting properties (Technical Appendix Figure). In all locations but 1, ELISA-positive results were confirmed by VNT for NT-Abs to WNV, BAGV, or USUV. Of them, neutralizing antibodies to only WNV were detected in 2 locations, whereas neutralizing antibodies to at least 2 (WNV/USUV or WNV/BAGV) of the 3 flaviviruses were detected in 8 locations. Within these locations, flavivirus-specific NT-Ab responses were differentiated in several samples: neutralizing antibodies to either WNV or BAGV were detected in samples from 6 locations, whereas samples with neutralizing antibodies to either WNV or USUV were detected in 1 location.Analysis of VNT results in juvenile partridges showed specific neutralizing antibodies to WNV (13%) or BAGV (9%); 4% of these samples were positive for flavivirus but inconclusive for any of the flaviviruses tested (Table). Overall, these results indicated recent circulation of 3 different epornitic flaviviruses—WNV, USUV, and BAGV—in resident game birds in Cadiz, the southernmost province in Spain. A high proportion of birds showed neutralizing antibodies to >1 flavivirus. Some are likely to be attributable to cross-neutralization, although co-infection cannot be ruled out because the results showed co-circulation of >1 flavivirus in game birds in most locations studied. Furthermore, the presence of specific neutralizing antibodies in juvenile partridges indicated that WNV and BAGV circulated in the area 1 year after the outbreaks of 2010. For USUV, specific neutralizing antibodies were detected only in an adult partridge, indicating infection acquired during the previous years. Nevertheless, this finding does not rule out recent co-circulation of USUV together with the other 2 viruses in the same game bird populations, considering that USUV has been repeatedly detected in mosquitoes in nearby areas (4).Evidence of infection by at least WNV and BAGV in 2 consecutive seasons strongly supports the premise that these viruses overwintered in the area. Capability of WNV to overwinter in southern Europe was shown in Italy during 2008–2009 (9) and in Spain during 2007–2008 (10). Overwintering of BAGV after its introduction into Spain could indicate a risk for its expansion in areas with similar climates (Mediterranean basin). The risk for dissemination of WNV, BAGV, or USUV infections not only to game birds, but also to other wildlife, domestic animals, and humans, calls for improvements in surveillance programs, particularly those that monitor susceptible hosts, such as game birds.Technical Appendix: Study area in Spain (province of Cadiz) showing the position of hunting properties analyzed.Click here to view.(101K, pdf)" @default.
• W2079301085 created "2016-06-24" @default.
• W2079301085 creator A5011596307 @default.
• W2079301085 creator A5040163610 @default.
• W2079301085 creator A5063469614 @default.
• W2079301085 creator A5066927962 @default.
• W2079301085 creator A5072550218 @default.
• W2079301085 creator A5080470375 @default.
• W2079301085 date "2013-06-01" @default.
• W2079301085 modified "2023-09-30" @default.
• W2079301085 title "Flaviviruses in Game Birds, Southern Spain, 2011–2012" @default.
• W2079301085 cites W1899606749 @default.
• W2079301085 cites W1978164629 @default.
• W2079301085 cites W2014455132 @default.
• W2079301085 cites W2070822978 @default.
• W2079301085 cites W2076196238 @default.
• W2079301085 cites W2087116215 @default.
• W2079301085 cites W2100651200 @default.
• W2079301085 cites W2163283459 @default.
• W2079301085 cites W2615515747 @default.
• W2079301085 doi "https://doi.org/10.3201/eid1906.130122" @default.
• W2079301085 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3713840" @default.
• W2079301085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23735195" @default.
• W2079301085 hasPublicationYear "2013" @default.
• W2079301085 type Work @default.
• W2079301085 sameAs 2079301085 @default.
• W2079301085 citedByCount "38" @default.
• W2079301085 countsByYear W20793010852013 @default.
• W2079301085 countsByYear W20793010852014 @default.
• W2079301085 countsByYear W20793010852015 @default.
• W2079301085 countsByYear W20793010852016 @default.
• W2079301085 countsByYear W20793010852018 @default.
• W2079301085 countsByYear W20793010852019 @default.
• W2079301085 countsByYear W20793010852020 @default.
• W2079301085 countsByYear W20793010852021 @default.
• W2079301085 countsByYear W20793010852022 @default.
• W2079301085 countsByYear W20793010852023 @default.
• W2079301085 crossrefType "journal-article" @default.
• W2079301085 hasAuthorship W2079301085A5011596307 @default.
• W2079301085 hasAuthorship W2079301085A5040163610 @default.
• W2079301085 hasAuthorship W2079301085A5063469614 @default.
• W2079301085 hasAuthorship W2079301085A5066927962 @default.
• W2079301085 hasAuthorship W2079301085A5072550218 @default.
• W2079301085 hasAuthorship W2079301085A5080470375 @default.
• W2079301085 hasBestOaLocation W20793010851 @default.
• W2079301085 hasConcept C205649164 @default.
• W2079301085 hasConcept C86803240 @default.
• W2079301085 hasConcept C90856448 @default.
• W2079301085 hasConceptScore W2079301085C205649164 @default.
• W2079301085 hasConceptScore W2079301085C86803240 @default.
• W2079301085 hasConceptScore W2079301085C90856448 @default.
• W2079301085 hasIssue "6" @default.
• W2079301085 hasLocation W20793010851 @default.
• W2079301085 hasLocation W20793010852 @default.
• W2079301085 hasLocation W20793010853 @default.
• W2079301085 hasLocation W20793010854 @default.
• W2079301085 hasLocation W20793010855 @default.
• W2079301085 hasLocation W20793010856 @default.
• W2079301085 hasOpenAccess W2079301085 @default.
• W2079301085 hasPrimaryLocation W20793010851 @default.
• W2079301085 hasRelatedWork W1995175941 @default.
• W2079301085 hasRelatedWork W2046971378 @default.
• W2079301085 hasRelatedWork W2058747951 @default.
• W2079301085 hasRelatedWork W2316530170 @default.
• W2079301085 hasRelatedWork W2334504660 @default.
• W2079301085 hasRelatedWork W2746595942 @default.
• W2079301085 hasRelatedWork W2937117390 @default.
• W2079301085 hasRelatedWork W2947686229 @default.
• W2079301085 hasRelatedWork W4240323839 @default.
• W2079301085 hasRelatedWork W4244628857 @default.
• W2079301085 hasVolume "19" @default.
• W2079301085 isParatext "false" @default.
• W2079301085 isRetracted "false" @default.
• W2079301085 magId "2079301085" @default.
• W2079301085 workType "article" @default.